May 11 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® REPORTS 2018 FIRST QUARTER RESULTS
* ONCOLYTICS BIOTECH INC - QTRLY BASIC AND DILUTED LOSS PER COMMON SHARE $0.03
* ONCOLYTICS BIOTECH INC - AT MARCH 31, 2018, CO REPORTED $7.7 MILLION IN CASH AND CASH EQUIVALENTS
* ONCOLYTICS BIOTECH INC - ALL DOLLAR AMOUNTS ARE CANADIAN
* ONCOLYTICS - ADVANCED PLANS TO RELIST CO'S SHARES ON NASDAQ CAPITAL MARKET EXCHANGE, CONTINUES TO EVALUATE TIMING OF THIS ACTION